Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease
Emil Hagström, Claes Held, Ralph Stewart, et al.
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 325-333
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
Kai C. Wollert, Tibor Kempf, Lars Wallentin
Clinical Chemistry (2016) Vol. 63, Iss. 1, pp. 140-151
Open Access | Times Cited: 453
GDF15 and Growth Control
Paul J. Emmerson, Kevin L. Duffin, Sudhakar Chintharlapalli, et al.
Frontiers in Physiology (2018) Vol. 9
Open Access | Times Cited: 145
A Multi-omic Association Study of Trimethylamine N-Oxide
Ohad Manor, Niha Zubair, Matthew P. Conomos, et al.
Cell Reports (2018) Vol. 24, Iss. 4, pp. 935-946
Open Access | Times Cited: 142
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation
Lars Wallentin, Johan Lindbäck, Niclas Eriksson, et al.
European Heart Journal (2020) Vol. 41, Iss. 41, pp. 4037-4046
Open Access | Times Cited: 117
Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets
Luc Rochette, Marianne Zeller, Yves Cottin, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 12, pp. 939-951
Open Access | Times Cited: 116
GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD
Courtney Tuegel, Ronit Katz, Mariam Alam, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 4, pp. 519-528
Open Access | Times Cited: 102
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
Lars Wallentin, Niclas Eriksson, M Olszowka, et al.
PLoS Medicine (2021) Vol. 18, Iss. 1, pp. e1003513-e1003513
Open Access | Times Cited: 101
The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis
Lina Badimón, Gemma Vilahur, Bianca Rocca, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 9, pp. 2001-2015
Open Access | Times Cited: 99
GDF15 and Cardiac Cells: Current Concepts and New Insights
Luc Rochette, Geoffrey Dogon, Marianne Zeller, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8889-8889
Open Access | Times Cited: 97
Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production
Weijie Du, Arnold Piek, Elisabeth M. Schouten, et al.
Theranostics (2018) Vol. 8, Iss. 15, pp. 4155-4169
Open Access | Times Cited: 84
Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis
Elisa D’Alessandro, Christian Becker, Wolfgang Bergmeier, et al.
Thrombosis and Haemostasis (2020) Vol. 120, Iss. 04, pp. 538-564
Open Access | Times Cited: 81
Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease
Juan Wang, Liqun Wei, Xinchun Yang, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 17
Open Access | Times Cited: 79
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
Eri Kato, David A. Morrow, Chirk Jenn Ng, et al.
European Heart Journal (2022) Vol. 44, Iss. 4, pp. 293-300
Open Access | Times Cited: 61
Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease – A STABILITY Substudy
Claes Held, Nermin Hadziosmanovic, Philip E. Aylward, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 52
Growth and differentiation factor-15: A link between inflammaging and cardiovascular disease
Balázs Bence Nyárády, Loretta Kiss, Zsolt Bagyura, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116475-116475
Open Access | Times Cited: 10
Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes
Daniel Lindholm, Stefan James, Katja Gabrysch, et al.
JAMA Cardiology (2018) Vol. 3, Iss. 12, pp. 1160-1160
Open Access | Times Cited: 64
Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults
Richard D. Semba, Marta González‐Freire, Toshiko Tanaka, et al.
The Journals of Gerontology Series A (2019) Vol. 75, Iss. 1, pp. 175-180
Open Access | Times Cited: 62
Reference ranges for GDF-15, and risk factors associated with GDF-15, in a large general population cohort
Paul Welsh, Dorien M. Kimenai, Riccardo E. Marioni, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2022) Vol. 60, Iss. 11, pp. 1820-1829
Open Access | Times Cited: 34
Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management
Khalid Sawalha, Nicholas B. Norgard, Betty M. Drees, et al.
Current Heart Failure Reports (2023) Vol. 20, Iss. 4, pp. 287-299
Closed Access | Times Cited: 16
Biological basis and treatment of frailty and sarcopenia
Ryosuke Sato, Mirela Vatic, Guilherme Wesley Peixoto da Fonseca, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 9, pp. 982-998
Open Access | Times Cited: 6
Growth differentiation factor-15 is associated with cardiovascular outcomes in patients with coronary artery disease
Man Li, Lei Duan, Yulun Cai, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 46
Multimarker approach including CRP, sST2 and GDF‐15 for prognostic stratification in stable heart failure
Nils Kuster, Fabien Huet, Anne‐Marie Dupuy, et al.
ESC Heart Failure (2020) Vol. 7, Iss. 5, pp. 2230-2239
Open Access | Times Cited: 45
GDF-15 como Biomarcador em Doenças Cardiovasculares
Bruna Miers May, Maurício Pimentel, Leandro Ioschpe Zimerman, et al.
Arquivos Brasileiros de Cardiologia (2021)
Open Access | Times Cited: 35
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 34
Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress
Jessica Cedervall, Melanie Herre, Anca Dragomir, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top